Differential gene expression in peripheral blood lymphocytes of cancer patients treated with whole body hyperthermia and chemotherapy: A pilot study

International Journal of Hyperthermia

Volumn 22, Issue 8, 2006, Pages 625-635

  Hildebrandt, Bert ^a   Schoeler, Dagmar ^a   Ringel, Frauke ^b   Kerner, Thoralf ^c   Wust, Peter ^d   Riess, Hanno ^a   Schriever, Folke ^b  

^a Medizinische Klinik Mit Schwerpunkt Psychosomatik   (Germany)

^b Biomedizinisches Forschungszentrum   (Germany)

^c Klinik für Anästhesiologie und operative Intensivmedizin   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anti neoplastic combined chemotherapy protocols; Gene expression profiling; Heat shock proteins; Induced hyperthermia; Lymphocytes

Indexed keywords

ANTINEOPLASTIC AGENT; CALCYCLIN; CALCYCLIN BINDING PROTEIN; CARBOPLATIN; COMPLEMENTARY DNA; CYTOSTATIC AGENT; FLUOROURACIL; FOLINIC ACID; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90A; HEAT SHOCK PROTEIN 90B; HEMOGLOBIN BETA CHAIN; IFOSFAMIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MITOMYCIN C; OXALIPLATIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CELL STIMULATION; CELLULAR IMMUNITY; COLORECTAL CANCER; CYSTADENOCARCINOMA; DNA LIBRARY; DNA SEQUENCE; DOT HYBRIDIZATION; EFFECTOR CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC CODE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OVARY CANCER; PAROTID GLAND CARCINOMA; PERIPHERAL LYMPHOCYTE; PILOT STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CALCIUM-BINDING PROTEINS; COMBINED MODALITY THERAPY; GENE EXPRESSION PROFILING; GLOBINS; HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; LYMPHOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 33847367676     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730601074144     Document Type: Article

References (40)

1. Dewhirst, MW,.Viglianti, BL,.Lora-Michiels, M.,.Hanson, M. and Hoopes, PJ (2003) Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia, 19, pp. 267-294.
2. Hildebrandt, B.,.Wust, P.,.Ahlers, O.,.Dieing, A.,.Sreenivasa, G.,.Kerner, T.,.Felix, R. and Riess, H. (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol, 43, pp. 33-56.
3. Jaattelä, M. (1999) Heat shock proteins as cellular lifeguards. Ann Med, 31, pp. 261-271.
4. Kampinga, HH,.Dynlacht, JR and Dikomey, E. (2004) Mechanism of radiosensitization by hyperthermia (≥43°C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia, 20, pp. 131-139.
5. Lepock, JR (2003) Cellular effects of hyperthermia: Relevance to the minimum dose for thermal damage. Int J Hyperthermia, 19, pp. 252-266.
6. Urano, M.,.Kuroda, M. and Nishimura, Y. (1999) For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia, 15, pp. 79-107.
7. Repasky, E. and Issels, R. (2002) Physiological consequences of hyperthermia: Heat, heat shock proteins and the immune response. Int J Hyperthermia, 18, pp. 486-489.
8. Li, CY and Dewhirst, MW (2002) Hyperthermia-regulated immunogene therapy. Int J Hyperthermia, 18, pp. 586-596.
9. Manjili, MH,.Wang, XY,.Park, J.,.Macdonald, IJ,.Van Schie, RC and Subjeck, JR (2002) Cancer immunotherapy: Stress proteins and hyperthermia. Int J Hyperthermia, 18, pp. 506-520.
10. Hammami, MM,.Bouchama, A.,.Shail, E.,.Enein, HY Aboul and Sedairy, S al (1998) Lymphocyte subsets and adhesion molecules expression in heatstroke and heat stress. J Appl Physiol, 84, pp. 1615-1621.
11. Blazickova, S.,.Rovensky, J.,.Koska, J. and Vigas, M. (2000) Effect of hyperthermic water bath on parameters of cellular immunity. Int J Clin Pharmacol Res, 20, pp. 41-46.
12. Downing, JF and Taylor, MW (1987) The effect of in vivo hyperthermia on selected cytokines in men. Lymphokine Res, 6, pp. 103-109.
13. Kappel, M.,.Stadeager, C.,.Tvede, N.,.Galbo, H. and Pedersen, BK (1991) Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clin Exp Immunol, 84, pp. 175-180.
14. Kraybill, WG,.Olenki, T.,.Evans, SS,.Ostberg, JR,.O'Leary, KA,.Gibbs, JF and Repasky, EA (2002) A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: Correlation with mouse models. Int J Hyperthermia, 18, pp. 253-266.
15. Ahlers, O.,.Hildebrandt, B.,.Dieing, A.,.Deja, M.,.Bohnke, T.,.Wust, P.,.Riess, H.,.Gerlach, H. and Kerner, T. (2005) Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2°C. Eur J Appl Physiol, 95, pp. 298-306.
16. Atanackovic, D.,.Nierhaus, A.,.Neumeier, M.,.Hossfeld, DK and Hegewisch-Becker, S. (2002) 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother, 51, pp. 603-613.
17. Katschinski, D.,.Wiedemann, GJ,.Longo, W.,.d'Oleire, FR,.Spriggs, D. and Robins, HI (1999) Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy. Cytokine Growth Factor Rev, 10, pp. 93-97.
18. Robins, HI,.Kutz, M.,.Wiedemann, GJ,.Katschinski, DM,.Paul, D.,.Grosen, E.,.Tiggelaar, CL,.Spriggs, D.,.Gillis, W. and D'Oleire, F. (1995) Cytokine induction by 41.8°C whole body hyperthermia. Cancer Lett, 97, pp. 195-201.
19. Hildebrandt, B.,.Drager, J.,.Kerner, T.,.Deja, M.,.Loffel, J.,.Stroszczynski, C.,.Ahlers, O.,.Felix, R.,.Riess, H. and Wust, P. (2004) Whole-body hyperthermia in the scope of von Ardenne's systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: A phase I/II study. Int J Hyperthermia, 20, pp. 317-333.
20. Hegewisch-Becker, S.,.Gruber, Y.,.Corovic, A.,.Pichlmeier, U.,.Atanackovic, D.,.Nierhaus, A. and Hossfeld, DK (2002) Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: A phase II study. Ann Oncol, 13, pp. 1197-1204.
21. Strobl, B.,.Janni, W.,.Rjosk, D.,.Rack, BK,.Kornya, L.,.Bakhshandeh-Bath, A.,.Hegewisch-Becker, S.,.Hildebrandt, B. and Sommer, HL (2002) Chemotherapy with carboplatin/ifosfamide combined with whole body hyperthermia in recurrent ovarian cancer-results of a phase II study (Dolphin-1-Study). Proc Am Soc Clin Oncol, 19, p. 2523.
22. Hildebrandt, B.,.Hegewisch-Becker, S.,.Kerner, T.,.Nierhaus, A.,.Bakhshandeh-Bath, A.,.Janni, W.,.Sommer, H.,.Riess, H. and Wust, P. (2005) Current status of radiant whole-body hyperthermia at temperatures >41.5. Int J Hyperthermia, 21, pp. 169-183.
23. Kerner, T.,.Deja, M.,.Ahlers, O.,.Loeffel, J.,.Hildebrandt, B.,.Wust, P.,.Gerlach, H. and Riess, H. (1999) Whole body hyperthermia: A secure procedure for patients with various malignancies?. Intensive Care Med, 25, pp. 959-965.
24. Kerner, T.,.Hildebrandt, B.,.Ahlers, O.,.Deja, M.,.Riess, H.,.Draeger, J.,.Wust, P. and Gerlach, H. (2003) Anaesthesiological experiences with whole body hyperthermia. Int J Hyperthermia, 19, pp. 1-12.
25. Diatchenko, L.,.Lau, YF,.Campbell, AP,.Chenchik, A.,.Moqadam, F.,.Huang, B.,.Lukyanov, S.,.Lukyanov, K.,.Gurskaya, N. and Sverdlov, ED (1996) Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA, 93, pp. 6025-6030.
26. Buchner, J. (1996) Supervising the fold: Functional principles of molecular chaperones. FASEB J, 10, pp. 10-19.
27. Garrido, C.,.Gurbuxani, S.,.Ravagnan, L. and Kroemer, G. (2001) Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem Biophys Res Comm, 286, pp. 433-442.
28. Srivastava, P. (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol, 2, pp. 185-194.
29. Menoret, A. and Chandawarkar, R. (1998) Heat-shock protein-based anticancer immunotherapy: An idea whose time has come. Semin Oncol, 25, pp. 654-660.
30. Tamura, Y.,.Peng, P.,.Liu, K.,.Daou, M. and Srivastava, PK (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science, 278, pp. 117-120.
31. Narita, N.,.Noda, I.,.Ohtsubo, T.,.Fujieda, S.,.Tokuriki, M.,.Saito, T. and Saito, H. (2002) Analysis of heat-shock related gene expression in head-and-neck cancer using cDNA arrays. Int J Radiat Oncol Biol Phys, 53, pp. 190-196.
32. Zhang, HJ,.Drake, VJ,.Morrison, JP,.Oberley, LW and Kregel, KC (2002) Selected contribution: Differential expression of stress-related genes with aging and hyperthermia. J Appl Physiol, 92, pp. 1762-1769.
33. Kregel, KC (2002) Heat shock proteins: Modifying factors in physiological stress response and aquired thermotolerance. J Appl Physiol, 92, pp. 2177-2186.
34. Multhoff, G. (2002) Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia, 18, pp. 576-585.
35. Guo, XJ,.Chambers, AF,.Parfett, CL,.Waterhouse, P.,.Murphy, LC,.Reid, RE,.Craig, AM,.Edwards, DR and Denhardt, DTI (1990) Dentification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: Tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ, 1, pp. 333-338.
36. Rossi, AM and Hirschhorn, RR (1991) Expression of growth-regulated genes in normal and SV40 transformed hamster fibroblasts. J Cell Biochem, 47, pp. 165-173.
37. Chiba, T.,.Nagata, Y.,.Kishi, A.,.Sakamaki, K.,.Miyajima, A.,.Yamamoto, M.,.Engel, JD and Todokoro, K. (1993) Induction of erythroid-specific gene expression in lymphoid cells. Proc Natl Acad Sci USA, 90, pp. 11593-11597.
38. Razin, SV,.Ioudinkova, ES and Scherrer, K. (2000) Extensive methylation of a part of the CpG island located 3.0-4.5 kbp upstream to the chicken alpha-globin gene cluster may contribute to silencing the globin genes in non-erythroid cells. J Mol Biol, 299, pp. 845-852.
39. Dorner, BG,.Scheffold, A.,.Rolph, MS,.Huser, MB,.Kaufmann, SH,.Radbruch, A.,.Flesch, IE and Kroczek, RA (2002) MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci USA, 99, pp. 6181-6186.
40. Minano, FJ,.Fernandez-Alonso, A.,.Myers, RD and Sancibrian, M. (1996) Hypothalamic interaction between macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta in rats: A new level for fever control?. J Physiol, 491, pp. 209-217.